Effect of Acute Protein Supplementation in Diabetic Patients

NCT06880614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-09

No results posted yet for this study

Summary

The goal of this trial is to test the effect of house cricket (Acheta domesticus) preload on glycemic response in diabetic patients. The main question\[s\] it aims to answer are: whether house cricket powder could lower blood glucose spike and stimulate higher insulin response. Participants will consume either house cricket powder, whey protein isolate or placebo which will be mixed with a chicken-flavored soup. Participants fingers will be pricked for up to 2 hours.

Researcher will compare house cricket powder with placebo to see if the glycemic response is better in house cricket supplemented group.

Researcher will compare house cricket powder with whey protein isolate to see if both supplement induce comparable glycemic response.

Conditions

  • Diabetes Mellitus Type 2

Interventions

DIAGNOSTIC_TEST

Oral Glucose Tolerance test (75g 2-hour)

The participants are required to drink a glucose solution containing 75 g of glucose dissolved in 250 mL of water

DIETARY_SUPPLEMENT

Whey

Supplemented with whey protein isolate masked with a chicken-flavored soup

DIETARY_SUPPLEMENT

House cricket

Supplemented with house cricket powder masked with chicken-flavored soup

DIETARY_SUPPLEMENT

Placebo

Placebo consists of chicken-flavored soup without any supplement inside

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Ashril Yusof, PhD · University of Malaya

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06880614 on ClinicalTrials.gov